Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000938672 | SCV001084490 | benign | MHC class II deficiency | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004716633 | SCV005289583 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000938672 | SCV002090738 | likely benign | MHC class II deficiency | 2019-10-23 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003960533 | SCV004776938 | likely benign | CIITA-related disorder | 2024-02-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |